Institutional investors purchased a net $621.0 thousand shares of ILMN during the quarter ended June 2017 and now own 95.57% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINSLOW CAPITAL MANAGEMENT LLC Bought 1.2 Million shares of Illumina Inc
HPM PARTNERS LLC Bought 749.4 Thousand shares of Illumina Inc
CITADEL ADVISORS LLC Bought 677.0 Thousand shares of Illumina Inc